Multivariate Cox regression analysis for renal dysfunction
| Renal dysfunction | ||||
|---|---|---|---|---|
| Univariate | Multivariate | |||
| HR (95% CI) | p Value | HR (95% CI) | p Value | |
| Age | 1.06 (1.03 to 1.08) | 0.01 | 1.02 (0.99 to 1.05) | 0.15 |
| Female | 0.58 (0.41 to 0.83) | 0.01 | 0.83 (0.50 to 1.39) | 0.48 |
| Weight | 0.97 (0.96 to 0.99) | 0.01 | 1.00 (0.98 to 1.02) | 0.98 |
| Smoker | 1.00 (0.71 to 1.42) | 0.99 | ||
| DM | 0.53 (0.37 to 0.74) | 0.01 | 0.63 (0.42 to 0.94) | 0.02 |
| Dyslipidemia | 1.27 (0.88 to 1.82) | 0.19 | ||
| Last creatinine | 1.39 (1.15 to 1.69) | 0.01 | 1.22 (0.82 to 1.82) | 0.34 |
| Creatinine-based eGFR | 0.99 (0.98 to 0.99) | 0.01 | 1.02 (1.01 to 1.03) | 0.01 |
| COPD | 0.37 (0.18 to 0.74) | 0.01 | 0.71 (0.33 to 1.53) | 0.39 |
| PAOD | 0.60 (0.37 to 0.99) | 0.05 | 0.81 (0.46 to 1.43) | 0.46 |
| EuroSCORE | 1.08 (1.05 to 1.12) | 0.01 | 1.03 (0.98 to 1.09) | 0.26 |
| NYHA (3,4) | 0.50 (0.04 to 6.86) | 0.6 | ||
| LVEF | 0.99 (0.97 to 0.99) | 0.01 | 1.01 (0.98 to 1.03) | 0.64 |
| LVESD | 1.03 (1.01 to 1.05) | 0.01 | 1.02 (0.98 to 1.07) | 0.29 |
| Distal anastomosis | 0.99 (0.82 to 1.20) | 0.93 | ||
| Operation time | 1.00 (0.99 to 1.01) | 0.76 | ||
| Pre. cystatin C | 1.01 (0.98 to 1.04) | 0.04 | 0.96 (0.86 to 1.07) | 0.45 |
| Cystatin C-based eGFR | 3.66 (2.79 to 4.80) | 0.01 | 0.98 (0.96 to 0.99) | 0.03 |
| Group | ||||
| Low vs mid | 1.14 (0.38 to 3.48) | 0.8 | 0.37 (0.11 to 1.24) | 0.11 |
| Low vs high | 7.10 (2.64 to 19.12) | 0.01 | 0.35 (0.14 to 0.83) | 0.02 |
*p<0.05.
COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; EuroSCORE: European System for Cardiac Operative Risk Evaluation; LVESD, LV end-systolic dimension; NYHA, New York Heart Association; PAOD, peripheral artery occlusive disease.